Uncategorised - European Medical Journal

Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford

Onc Now: Episode 23: From Lab to Life in Breast Cancer Care

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Treatment Advances for Muscle-Invasive Bladder Cancer

Despite aggressive interventions, the five-year survival rate remains below 50% for those with localised disease and plummets to less than 15% when metastasis occurs.

AI Model Improves Survival Prediction in Patients with Fibrotic Lung Disease

A new AI model shows promise in predicting survival in patients with fibrotic lung disease, offering more precise prognosis than standard tests and imaging methods.

Early MRI Predicts Immunotherapy Response in Triple-Negative Breast Cancer

New MRI model predicts early treatment response in TNBC, supporting faster, more tailored clinical decisions.

Maternal Depression Linked to Adolescent Brain Connectivity Changes

Prenatal maternal depression alters brain connectivity patterns in children through adolescence, new large-cohort study reveals.

Canagliflozin Shows Promise for Children with Type 2 Diabetes

Learn how canagliflozin safely improves glycaemic control in children with Type 2 diabetes.

Cardio-Rheumatology Model Advances Systemic Sclerosis Care

A new interdisciplinary cardio-rheumatology model is paving the way for earlier detection and personalized treatment of cardiac complications in patients with systemic sclerosis, according to a recent review.

Olympic Combat Sports Boost Flexibility and Lower-Body Strength

The study examined six key outcomes: muscle strength, standing long jump, vertical jump (Sargent test), cardiorespiratory fitness, flexibility (sit-and-reach), and VO₂max.

Jade Williams and Isabel O'Brien, EMJ GOLD

Season 10’s insights, inspiration and ‘aha’ moments

Listen in to the standout moments from EMJ GOLD’s guests this season, uncovering the challenges and opportunities shaping today’s pharmaceutical industry.

Delaying Long-Acting HIV Therapy Increases Mortality

Delaying the rollout of long-acting injectable antiretroviral therapy (ART) in people with HIV and persistent viremia in the U.S. may result in thousands of avoidable deaths and years without viral suppression, according to new modeling data.